This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Canada's Sunnybrook Health Sciences Centre Joins Elekta And Philips Research Consortium On MRI-Guided Radiation Therapy

Today, the safety margin of normal tissue around the tumor absorbs a large portion of the radiation beam, adds Jean-Philippe Pignol, Professor of Radiation Oncology and a key leader on the Elekta partnership at Sunnybrook's Odette Cancer Centre. "The expectation is that MR-guided radiation therapy will enable us to treat more cancer tissue than normal tissue. In doing so, we could apply, in a single fraction, a huge dose to the tumor while avoiding side effects to normal tissues," he says.

"The development of advanced imaging solutions for oncology therapy planning and delivery is a key focus area for Philips," says Gene Saragnese, CEO Imaging Systems at Philips Healthcare. "Philips is already closely working together with Sunnybrook Health Sciences Centre in this field, and we welcome their expertise to the research consortium for MR guided radiotherapy. The members will jointly work on the design and implementation of the clinical studies with the objective of bringing image-guided oncology therapy to the next level, and ultimately creating the future of healthcare."

The integrated MRI-guided radiation therapy system is in development and not available for sale.

For further information, please contact: Johan Andersson, Director, Investor Relations, Elekta AB Tel: +46 702 100 451, email: johan.andersson@elekta.com    Time zone: CET: Central European Time

Michelle Joiner, Director, Global Public Relations and Brand Management, Elekta  Tel: +1 770-670-2447, email: michelle.joiner@elekta.com Time zone: ET: Eastern Time

Steve Klink, Philips Corporate Communications Tel: +31 20 5977415, email: steve.klink@philips.com  

About Elekta Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives. 

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,400 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.

About Royal Philips Electronics Royal Philips Electronics (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 116,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter.

SOURCE Elekta

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 16,643.01 -11.76 -0.07%
S&P 500 1,988.87 +1.21 0.06%
NASDAQ 4,828.3250 +15.6170 0.32%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs